Metastatic collecting duct (Bellini duct) carcinoma: A case report / 대한내과학회지
Korean Journal of Medicine
;
: 780-786, 2009.
Article
Dans Coréen
| WPRIM
| ID: wpr-137804
ABSTRACT
Renal cell carcinoma accounts for 2.6% of all cancer, and most renal cell carcinoma has a clear cell origin. Bellini duct carcinoma, which arises from collecting duct cells (Bellini cells), is a rare type of renal cell carcinoma, constituting less than 1% of all renal cell carcinoma. The prognosis of Bellini duct carcinoma is very poor, and more than 60% of the patients die within 2 years of diagnosis. There is no consensus regarding the optimal treatment. We report a case of Bellini duct carcinoma in a 53-year-old male with multiple lung and liver metastases. The patient was treated with eight cycles of M-VAC (methotrexate, vincristine, doxorubicin, and cisplatin) combination chemotherapy. The patient currently shows a radiological partial response without disease progression 10 months after the chemotherapy.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Pronostic
/
Vincristine
/
Néphrocarcinome
/
Doxorubicine
/
Évolution de la maladie
/
Consensus
/
Association de médicaments
/
Foie
/
Poumon
/
Métastase tumorale
Type d'étude:
Guide de pratique
/
Étude pronostique
Limites du sujet:
Humains
/
Mâle
langue:
Coréen
Texte intégral:
Korean Journal of Medicine
Année:
2009
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS